FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to obtaining cell lines intended for development of immunological approaches in treating melanoma, and can be used in medicine. Cell line of human skin melanoma mel Ibr EEMS is obtained from cell line of human skin melanoma mel Ibr. Obtained cell line is stored in Russian national collection of Industrial Microorganisms (VKPM) of FSUE GosNIIGenetika under registration number N-157.
EFFECT: invention enables to obtain a cell line of human skin melanoma, which has stable cultural and morphological characteristics and is characterised by the expression of antigens of class I histocompatibility, differentiation markers CD133, CD105, CD44 and absence of class II histocompatibility antigens.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN MELANOMA CELL LINE mel Z USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2390556C1 |
| HUMAN MELANOMA CELL LINE mel Ksen, USED FOR ANTITUMOUR VACCINES MANUFACTURE | 2008 |
|
RU2392316C1 |
| CELL LINE OF HUMAN MELANOMA mel Me, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402603C1 |
| HUMAN MELANOMA CELL LINE mel Gus, USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2373280C1 |
| HUMAN MELANOMA CELLULAR LINE mel Ibr USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287576C1 |
| HUMAN MELANOMA CELL LINES mel Si, USED FOR MAKING TUMOUR VACCINE | 2008 |
|
RU2363734C1 |
| CELL LINE OF HUMAN MELANOMA mel Mtp USED FOR MAKING ANTICANCER VACCINES | 2008 |
|
RU2360963C1 |
| CELL LINE OF HUMAN MELANOMA mel Rac, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402602C1 |
| CELL LINE OF HUMAN MELANOMA mel H, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402604C1 |
| CELL LINE OF HUMAN MELANOMA mel Cher, USED FOR OBTAINING ANTI-TUMOR VACCINES | 2008 |
|
RU2364624C1 |
